Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 13, 2008Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
Boston Scientific Corporation (NYSE: BSX) and the International Diabetes Federation (IDF) today announced that Boston...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA™ family of pacemakers....
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its...
-
Apr 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 5-7 in...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) today announced completion of enrollment in the Multicenter Automatic Defibrillator Implantation Trial...
-
Apr 23, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards...
-
Apr 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2008, as well as guidance for...
-
Apr 17, 2008Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval for the sale of its TAXUS® Liberte® paclitaxel-eluting...
-
Apr 16, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced the signing of a definitive...
-
Apr 15, 2008Emerging technology will potentially enable access to MRI exams for implantable cardiac device patients
Boston Scientific Corporation (NYSE: BSX) and Surgi-Vision, Inc., a privately held company, today announced a licensing and...
-
Apr 14, 2008ACUITY® Steerable lead also receives reimbursement approval; Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced Japanese Ministry of Health, Labor and Welfare (MHLW) approval of its ACUITY® Steerable...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31,...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Timothy Pratt as its new General Counsel. Pratt is a nationally...
-
Apr 2, 2008Judgment entered in favor of Guidant and its former directors/officers
Boston Scientific Corporation (NYSE: BSX) today announced that United States District Judge Sarah Evans Barker, Indianapolis, dismissed...
-
Apr 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled analysis of patients from its TAXUS IV and TAXUS...
-
Apr 1, 2008Results from TAXUS IV and V randomized clinical trials favor DES compared to bare-metal stents
Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V...
-
Mar 31, 2008At two years, Company's TAXUS® and PROMUS™ Stents demonstrate positive and similar outcomes
Boston Scientific Corporation (NYSE: BSX) today welcomed positive two-year results from Abbott's prospective, randomized (3:1), single...
-
Mar 31, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of two-year data from more than 7,000 patients in...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 4,772 patients from its TAXUS ARRIVE 1 and 2...
-
Mar 25, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for...
-
Mar 11, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 18...